Dapagliflozin Effect on Cardiovascular Events A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients With Type 2 Diabetes
Dapagliflozin Effect on Cardiovascular Events A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients With Type 2 Diabetes
This study is being carried out to determine the effect of dapagliflozin on cardiovacular outcomes when added to current background therapy in patients with type 2 diabetes with either established cardiovacular disease or cardiovascular risk factors.
Inclusion Criteria:
Exclusion Criteria:
Parma Hts., Ohio 44130, United States
CABA, C1093AAS, Argentina
Ciudad Autonoma Buenos Aires, C1181ACH, Argentina
Ciudad Autonoma de Buenos Aire, C1120AAC, Argentina
Adelaide - Oaklands Park, 5046, Australia
North York, Ontario M3J 1N2, Canada
Chrudim III, 537 01, Czechia
Ostrava - Belsky Les, 700 30, Czechia
Ostrava - Dubina, 700 30, Czechia
Ostrava-Moravska, 702 00, Czechia
Plzen - Severni Predmesti, 301 00, Czechia
Ballasagyarmat, 2660, Hungary
Bnei Barak, 5136166, Israel
Negrar - VR, 37024, Italy
S Maria Capua Vetere, 81055, Italy
Daito-shi, 574-0074, Japan
Kasuga-shi, 816-0864, Japan
Matsubara-shi, 580-0032, Japan
Ube-shi, 755-8505, Japan
Uji-shi, 611-0041, Japan
Del. Cuauhtemoc, 06700, Mexico
Meridas, 97070, Mexico
Zapopan, Jalisco, 45200, Mexico
Târgu Mures, 540136, Romania
Diepkloof, Soweto, 2013, South Africa
Muckleneuk, 0002, South Africa
Parktown West, 2193, South Africa
Järfälla, 177 30, Sweden
Muang, 40002, Thailand
Phisanulok, 65000, Thailand
Rajthevi, 10400, Thailand
Vynnitsa, 21018, Ukraine
Mortimer Reading, RG7 3SQ, United Kingdom